BIOMAT Database Logo BIOMAT Database Logo

Heterologous protection against influenza by injection of DNA encoding a viral protein. 1993

J B Ulmer, and J J Donnelly, and S E Parker, and G H Rhodes, and P L Felgner, and V J Dwarki, and S H Gromkowski, and R R Deck, and C M DeWitt, and A Friedman
Department of Cancer Research, Merck Research Laboratories, West Point, PA 19486.

Cytotoxic T lymphocytes (CTLs) specific for conserved viral antigens can respond to different strains of virus, in contrast to antibodies, which are generally strain-specific. The generation of such CTLs in vivo usually requires endogenous expression of the antigen, as occurs in the case of virus infection. To generate a viral antigen for presentation to the immune system without the limitations of direct peptide delivery or viral vectors, plasmid DNA encoding influenza A nucleoprotein was injected into the quadriceps of BALB/c mice. This resulted in the generation of nucleoprotein-specific CTLs and protection from a subsequent challenge with a heterologous strain of influenza A virus, as measured by decreased viral lung titers, inhibition of mass loss, and increased survival.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009132 Muscles Contractile tissue that produces movement in animals. Muscle Tissue,Muscle,Muscle Tissues,Tissue, Muscle,Tissues, Muscle
D009698 Nucleoproteins Proteins conjugated with nucleic acids. Nucleoprotein
D009976 Orthomyxoviridae Infections Virus diseases caused by the ORTHOMYXOVIRIDAE. Orthomyxovirus Infections,Infections, Orthomyxoviridae,Infections, Orthomyxovirus,Swine Influenza,Infection, Orthomyxoviridae,Infection, Orthomyxovirus,Influenza, Swine,Orthomyxoviridae Infection,Orthomyxovirus Infection
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA

Related Publications

J B Ulmer, and J J Donnelly, and S E Parker, and G H Rhodes, and P L Felgner, and V J Dwarki, and S H Gromkowski, and R R Deck, and C M DeWitt, and A Friedman
Mechanism of protection against influenza A virus by DNA vaccine encoding the hemagglutinin gene.
January 2000, Intervirology,
J B Ulmer, and J J Donnelly, and S E Parker, and G H Rhodes, and P L Felgner, and V J Dwarki, and S H Gromkowski, and R R Deck, and C M DeWitt, and A Friedman
Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
October 1994, Proceedings of the National Academy of Sciences of the United States of America,
J B Ulmer, and J J Donnelly, and S E Parker, and G H Rhodes, and P L Felgner, and V J Dwarki, and S H Gromkowski, and R R Deck, and C M DeWitt, and A Friedman
Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major.
February 1995, Immunology,
J B Ulmer, and J J Donnelly, and S E Parker, and G H Rhodes, and P L Felgner, and V J Dwarki, and S H Gromkowski, and R R Deck, and C M DeWitt, and A Friedman
Protection against lethal influenza with a viral mimic.
August 2013, Journal of virology,
J B Ulmer, and J J Donnelly, and S E Parker, and G H Rhodes, and P L Felgner, and V J Dwarki, and S H Gromkowski, and R R Deck, and C M DeWitt, and A Friedman
Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV.
May 2023, Scientific reports,
J B Ulmer, and J J Donnelly, and S E Parker, and G H Rhodes, and P L Felgner, and V J Dwarki, and S H Gromkowski, and R R Deck, and C M DeWitt, and A Friedman
Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant.
January 2005, Viral immunology,
J B Ulmer, and J J Donnelly, and S E Parker, and G H Rhodes, and P L Felgner, and V J Dwarki, and S H Gromkowski, and R R Deck, and C M DeWitt, and A Friedman
Influenza Chimeric Protein (3M2e-3HA2-NP) Adjuvanted with PGA/Alum Confers Cross-Protection against Heterologous Influenza A Viruses.
February 2021, Journal of microbiology and biotechnology,
J B Ulmer, and J J Donnelly, and S E Parker, and G H Rhodes, and P L Felgner, and V J Dwarki, and S H Gromkowski, and R R Deck, and C M DeWitt, and A Friedman
Essential sequence of influenza neuraminidase DNA to provide protection against lethal viral infection.
April 2006, DNA and cell biology,
J B Ulmer, and J J Donnelly, and S E Parker, and G H Rhodes, and P L Felgner, and V J Dwarki, and S H Gromkowski, and R R Deck, and C M DeWitt, and A Friedman
Protection against influenza virus challenge by topical application of influenza DNA vaccine.
August 2001, Vaccine,
J B Ulmer, and J J Donnelly, and S E Parker, and G H Rhodes, and P L Felgner, and V J Dwarki, and S H Gromkowski, and R R Deck, and C M DeWitt, and A Friedman
Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection.
August 2021, Vaccine,
Copied contents to your clipboard!